Canopy Growth (NYSE:CGC)

  • Symbol:NYSE:CGC
  • Ticker 2:CSE:WEED
  • Sector:Healthcare
  • Industry:Pharmaceutical
  • CEO:Mark Zekulin
  • Founded:2013

Canopy Growth (NYSE:CGC) Stock Price

Canopy Growth (NYSE:CGC) Company Overview

Smith's Falls has a population of 8,978. The town itself is beautiful and quaint, with the main street consisting of a couple of restaurants, a post office, and assorted mom-and-pop shops.

It used to be a bustling industrial town and was home to several large mills and factories — including the Hershey Chocolate factory, which served as the Canadian operation for the company since 1963. But Hershey decided in 2008 to shut the factory and move its operation to Mexico for the cheap labour.

It laid dormant until 2014, when Tweed Marijuana Inc. purchased the facility and set up shop. It was the first publicly-traded cannabis company in Canada. That set the stage for what is now considered to be the most impressive marijuana growing operation in North America.

What started as Tweed Marijuana Inc. has now grown into Canopy Growth Corp. (NYSE:CGC). Essentially the company has moulded itself into a large umbrella holding company that will include several holdings in different areas of the recreational and medical cannabis sector.

Canopy Growth Corp. is home to a burgeoning group of subsidiaries that produce medical marijuana, industry based-products and intellectual property. This acquisition strategy under Canopy will help them offer a diversified product line that will appeal to a wide array of customers, doctors and strategic industry partners.

Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.

Canopy Growth has established partnerships with leading sector names including cannabis icon Snoop Dogg, breeding legends DNA Genetics and Green House seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates seven cannabis production sites with over 665,000 square feet of production capacity, including over 500,000 square feet of GMP-certified production space. The Company has operations in seven countries across four continents.

Canopy Growth (NYSE:CGC) is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public's understanding of cannabis, and through its partly owned subsidiary, Canopy Health Innovations, has devoted millions of dollars toward cutting edge, commercializable research and IP development.

Through partly owned subsidiary Canopy Rivers Corporation, the Company is providing resources and investment to new market entrants and building a portfolio of stable investments in the sector.

Canopy Growth (NYSE:CGC) Financials

More From Canopy Growth...

Should you still buy pot stocks?
Match Point – KushCo Secures $50m Credit Facility and Strengthens Advisory Board
Licensed To Extract – Canopy Growth Receives Crucial Extraction License
Moving On Up – Canopy Rivers Receives Conditional Approval to be Listed on TSX
Global Takeover – Canopy Growth Acquires Beckley Canopy Therapeutics
Dry July for the Cannabis Industry
Canopy Growth Acquires Storz & Bickel Vaporizers
High Five – Spectrum Therapeutics Enters Into Five-Year Agreement With Medical Pharmacies
Weed Like Some More Please – Cannabis Edibles 101
Spectrum Therapeutics Partners with Canadian Mental Health Association
Load More Results

Investor Presentation

The latest update from the company

Click Here
Stay updated about
this company

Signup to get updates.


Rade Kovacevic
Rade Kovacevic has a history of being able to bring key stakeholders together on marijuana policy, as a Co-Founder and former President of the Canadian Association of Medical Cannabis Dispensaries and a Co-Founder and former Advocacy Committee Chair of the Canadian Medical Cannabis Industry Association.

He focused on Management Economics and Industry Finance while completing his Bachelor of Arts degree at the University of Guelph.
Mark Zekulin
President & Chief Executive Officer
Mark Zekulin has been with Canopy Growth since its inception, and has been a key driver of the company’s vision.

He is a graduate from the University of Waterloo in Mathematics, the University of Ottawa in Law, and the University of Cambridge in International Law, and previously provided legal, political and strategic advice to high- profile local and international corporate clients, including acting as Counsel for Cassidy Levy Kent.

Mike Lee
Chief Financial Officer
Mike Lee has previously worked with companies such as E. & J. Gallo Winery, PepsiCo, and recently Constellation Brands, where he served as Senior Vice President & CFO for their US$3B Wine & Spirits Division.

While working with Constellation Brands’ executive leadership he was instrumental in helping to transform their premium Wine & Spirits business.
Andre Fernandez
Chief Operating Officer
Andre Fernandez has worked primarily in manufacturing finance and asset management. He holds a Bachelor’s of Science in Civil Engineering from Queen’s University, and an MBA from the University of Toronto Rotman School of Management.

Fernandez previously spent time working as a geotechnical engineer primarily in oil & gas, and was also part of the team who implemented the world class manufacturing methodology to transform Chrysler when Fiat and Chrysler merged.